Idropranolol
Jump to navigation
Jump to search
This article was nominated for deletion. The discussion was closed on 23 December 2023 with a consensus to merge the content into the article Propranolol. If you find that such action has not been taken promptly, please consider assisting in the merger instead of re-nominating the article for deletion. To discuss the merger, please use the destination article's talk page. (December 2023) |
The topic of this article may not meet Wikipedia's notability guidelines for products and services. (August 2020) |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C16H23NO2 |
Molar mass | 261.365 g·mol−1 |
3D model (JSmol) | |
| |
|
Idropranolol is a beta blocker that was never marketed.[1][2]
References
- ^ Morton IK, Hall JM (Oct 31, 1999). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer. p. 150.
- ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 676. ISBN 978-1-4757-2085-3.
Categories:
- Articles to be merged after an Articles for deletion discussion
- Articles to be merged from December 2023
- Articles with short description
- Short description matches Wikidata
- Articles with topics of unclear notability from August 2020
- All articles with topics of unclear notability
- Products articles with topics of unclear notability
- Drugs not assigned an ATC code
- Drugs with non-standard legal status
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles containing unverified chemical infoboxes
- Beta blockers
- Abandoned drugs
- N-isopropyl-phenoxypropanolamines
- All stub articles
- Cardiovascular system drug stubs